Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Journal of Critical Care|March 17, 2023
Post-traumatic stress disorder and quality of life alterations in survivors of immune-mediated thrombotic thrombocytopenic purpura and atypical hemolytic and uremic syndromeElie Azoulay, Virginie Souppart, Nancy Kentish-Barnes, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2022
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES studyMarie Scully, Javier de la Rubia, Katerina Pavenski, et al.
Haematologica|May 14, 2016
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patientsCamille Laurent, Bettina Fabiani, Catherine Do, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2020
Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigenCharlotte Dekimpe, Elien Roose, Claudia Tersteeg, et al.
Lupus Science & Medicine|July 29, 2025
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcomeJúlia Weisinger, Raïda Bouzid, Jehane Fadlallah, et al.
Transfusion|March 13, 2012
Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceFrançois Beloncle, Marc Buffet, Jean-Philippe Coindre, et al.
Emerging Infectious Diseases|April 16, 2026
Hemolytic Uremic Syndrome Outbreak in Adults and Shiga Toxin-Producing Escherichia coli Negative for Locus of Enterocyte Effacement, France, 2025Justine de Larminat, Kevin La, Philippe Bidet, et al.
Blood|December 8, 2009
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeYenlin Huang, Aurélien de Reyniès, Laurence de Leval, et al.
Haematologica|February 18, 2021
Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpuraMatthew J Stubbs, Paul Coppo, Chris Cheshire, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomesAdrien Joseph, Stéphanie Harel, Laurent Mesnard, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Journal of Critical Care|March 17, 2023
Post-traumatic stress disorder and quality of life alterations in survivors of immune-mediated thrombotic thrombocytopenic purpura and atypical hemolytic and uremic syndromeElie Azoulay, Virginie Souppart, Nancy Kentish-Barnes, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2022
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES studyMarie Scully, Javier de la Rubia, Katerina Pavenski, et al.
Haematologica|May 14, 2016
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patientsCamille Laurent, Bettina Fabiani, Catherine Do, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2020
Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigenCharlotte Dekimpe, Elien Roose, Claudia Tersteeg, et al.
Lupus Science & Medicine|July 29, 2025
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcomeJúlia Weisinger, Raïda Bouzid, Jehane Fadlallah, et al.
Transfusion|March 13, 2012
Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceFrançois Beloncle, Marc Buffet, Jean-Philippe Coindre, et al.
Emerging Infectious Diseases|April 16, 2026
Hemolytic Uremic Syndrome Outbreak in Adults and Shiga Toxin-Producing Escherichia coli Negative for Locus of Enterocyte Effacement, France, 2025Justine de Larminat, Kevin La, Philippe Bidet, et al.
Blood|December 8, 2009
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeYenlin Huang, Aurélien de Reyniès, Laurence de Leval, et al.
Haematologica|February 18, 2021
Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpuraMatthew J Stubbs, Paul Coppo, Chris Cheshire, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomesAdrien Joseph, Stéphanie Harel, Laurent Mesnard, et al.
Pageof 20